SEC 13F Intelligence

Oppenheimer Asset Management Inc. / LLY

Oppenheimer Asset Management Inc.’s Eli Lilly & Co Position

Does Oppenheimer Asset Management Inc. own Eli Lilly & Co (LLY)? Yes — 69.2K shares worth $64M (+0.73% of its 13F portfolio) as of Q1 2026, up from 62.2K shares the prior filed quarter.

Position Value
$64M
Q1 2026
Shares
69.2K
% of Portfolio
+0.73%
Quarters Held
30
currently held

Position History LLY

Reported value by quarter
Q4 ’18: $35MQ4 ’18Q1 ’19: $32MQ2 ’19: $26MQ3 ’19: $26MQ4 ’19: $26MQ4 ’19Q1 ’20: $26MQ2 ’20: $22MQ3 ’20: $16MQ4 ’20: $17MQ4 ’20Q1 ’21: $16MQ2 ’21: $20MQ3 ’21: $17MQ4 ’21: $20MQ4 ’21Q1 ’22: $25MQ2 ’22: $21MQ3 ’22: $14MQ4 ’22: $15MQ4 ’22Q1 ’23: $15MQ2 ’23: $20MQ3 ’23: $22MQ4 ’23: $23MQ4 ’23Q1 ’24: $28MQ2 ’24: $36MQ3 ’24: $35MQ4 ’24: $48MQ4 ’24Q1 ’25: $65MQ2 ’25: $53MQ3 ’25: $50MQ4 ’25: $67MQ4 ’25Q1 ’26: $64Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 202669.2K$64M+0.73%
Q4 202562.2K$67M+0.82%
Q3 202565.5K$50M+0.55%
Q2 202568.3K$53M+0.61%
Q1 202578.3K$65M+0.80%
Q4 202461.8K$48M+0.58%
Q3 202439.3K$35M+0.42%
Q2 202439.4K$36M+0.46%
Q1 202436.2K$28M+0.41%
Q4 202340.2K$23M+0.33%
Q3 202340.4K$22M+0.33%
Q2 202342.5K$20M+0.29%
Q1 202343.3K$15M+0.23%
Q4 202241.9K$15M+0.25%
Q3 202242.9K$14M+0.24%
Q2 202265.4K$21M+0.36%
Q1 202287.5K$25M+0.36%
Q4 202171.5K$20M+0.26%
Q3 202172.2K$17M+0.24%
Q2 202188.8K$20M+0.29%
Q1 202183.8K$16M+0.24%
Q4 2020101.6K$17M+0.29%
Q3 2020106.6K$16M+0.31%
Q2 2020131.7K$22M+0.45%
Q1 2020186.7K$26M+0.64%
Q4 2019194.5K$26M+0.54%
Q3 2019230.1K$26M+0.57%
Q2 2019237.5K$26M+0.58%
Q1 2019246.3K$32M+0.72%
Q4 2018305.9K$35M+0.88%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Oppenheimer Asset Management Inc.’s full portfolio or all institutional holders of LLY.